title: Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management.
authors.forename: George
authors.initials: G
authors.lastname: Grunberger
authors.forename: Timothy Silleck
authors.initials: TS
authors.lastname: Bailey
authors.forename: A Jay
authors.initials: AJ
authors.lastname: Cohen
authors.forename: Thomas Michael
authors.initials: TM
authors.lastname: Flood
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Handelsman
authors.forename: Richard
authors.initials: R
authors.lastname: Hellman
authors.forename: Lois
authors.initials: L
authors.lastname: Jovanovič
authors.forename: Etie S
authors.initials: ES
authors.lastname: Moghissi
authors.forename: Eric A
authors.initials: EA
authors.lastname: Orzeck
mesh_terms: D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D004704:Endocrinology / Q000295:instrumentation / Q000379:methods / Q000458:organization & administration*; D005104:Expert Testimony; D006282:Health Personnel; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D055104:Infusions, Subcutaneous; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems / Q000706:statistics & numerical data*; D015201:Meta-Analysis as Topic; D008954:Models, Biological; D012955:Societies, Medical / Q000458:organization & administration; D014481:United States
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin